Cardiology

0.3(top 100%)

impact factor

211(top 50%)

papers

535(top 50%)

citations

12(top 50%)

h-index

0.3(top 100%)

extended IF

235

all documents

552

doc citations

17(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?	Cardiology	2004	38
2	Heart Failure in the Elderly: Characteristics of a Swedish Primary Health Care Population	Cardiology	2002	30
3	Value of N-Terminal proBNP in the Diagnosis of Left Ventricular Systolic Dysfunction in Primary Care Patients Referred for Echocardiography	Cardiology	2003	26
4	Influenza and Pneumococcal Vaccinations Fail to Prevent Myocardial Infarction	Cardiology	2004	21
5	Intervention with Clarithromycin in Patients with Stable Coronary Heart Disease	Cardiology	2001	19
6	Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction	Cardiology	2001	17
7	Hyperglycemia after Acute Ischemic Stroke: Prediction, Significance and Immediate Control with Insulin-Potassium-Saline-Magnesium Infusions	Cardiology	2005	14
8	Regional Inequality in the Risk of Acute Myocardial Infarction in Finland: A Case Study of 35- to 74-Year-Old Men	Cardiology	2002	13
9	Early Drug Therapy and In-Hospital Mortality following Acute Myocardial Infarction	Cardiology	2003	13
10	Standardization of Central Off-Line Quantitative Image Analysis: Implications from Experiences with Quantitative Coronary Angiography	Cardiology	2001	12
11	Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction	Cardiology	2001	12
12	Drug-Eluting Stents	Cardiology	2003	12
13	Evidence for the Benefits of the Low-Molecular-Weight Heparin Dalteparin in ‘High-Risk’ Patients with Acute Coronary Syndromes	Cardiology	2004	12
14	Incidence of and Predicting Factors for Torsades de Pointes during Intravenous Administration of Amiodarone	Cardiology	2001	11
15	The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background Population	Cardiology	2002	11
16	Beyond Traditional Risk Factors: Homocysteine and Atherosclerosis	Cardiology	2001	10
17	The Danish Multicenter Randomized Study on Atrial Inhibited versus Dual-Chamber Pacing in Sick Sinus Syndrome (The DANPACE Study)	Cardiology	2001	10
18	Blinded End Point Adjudication in the ‘Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction’ (DANAMI-2 Trial)	Cardiology	2003	10
19	Prognostic Comparison of the Minute Ventilation/Carbon Dioxide Production Ratio and Slope in Patients with Heart Failure	Cardiology	2004	9
20	Safety of Bone Marrow Stem Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor: 30 Days’ Blinded Clinical Results from the Stem Cells in Myocardial Infarction (STEMMI) Trial	Cardiology	2005	9
21	Effect of N-Acetylcysteine on Serum Creatinine Concentration in Patients with Chronic Renal Insufficiency Who Are Undergoing Coronary Angiography	Cardiology	2004	8
22	Amiodarone: The Last and/or Best Hope for Pharmacological Control of Cardiac Arrhythmias?	Cardiology	2001	7
23	Prior Aspirin Therapy, Subsequent Stroke Severity and Mortality and Relationship with Cardiovascular Risk Factors in Patients Admitted to Hospital with Acute Stroke	Cardiology	2002	7
24	Nicorandil – Review of Pharmacological Properties and Clinical Applications	Cardiology	2005	7
25	Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic Syndrome	Cardiology	2005	7
26	Trial of Invasive versus Medical Therapy in the Elderly (TIME)	Cardiology	2001	6
27	Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential Problems	Cardiology	2004	6
28	Changes in Peak Respiratory Flow and Quality of Life during Nebivolol Therapy	Cardiology	2004	6
29	Thromboembolic Prophylaxis with Fondaparinux in Major Orthopaedic Surgery: Outcomes and Costs	Cardiology	2005	6
30	Platelets and Thrombolysis: Cooperation or Contrariety?	Cardiology	2001	5
31	Additional Features of Beta-Blockers	Cardiology	2005	5
32	Rapid Effects of a Single High Dose of Simvastatin on C-Reactive Protein in Patients with Unstable Angina	Cardiology	2005	5
33	Potassium Must Be Considered in Congenital Long QT Syndrome	Cardiology	2005	5
34	Effect of ‘Drug Holiday’ on Blood Pressure Control: A Randomized Double-Blind Comparative Trial of Amlodipine versus Felodipine Extended Release in Chinese Patients with Mild to Moderate Essential Hypertension	Cardiology	2001	4
35	Promises and Problems of Systematic Reviews	Cardiology	2001	4
36	Observations on the Use of Low-Dose Hydrochlorothiazide in the Treatment of Hypertension in Diabetic Nigerians	Cardiology	2001	4
37	Cell Adhesion Molecules in Cardiovascular Pathology – A Glance into the Future?	Cardiology	2001	4
38	Intramyocardial Injection of Genes with a Novel Percutaneous Technique: Initial Safety Data of the Euroinject One Study	Cardiology	2001	4
39	Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart Failure	Cardiology	2002	4
40	Left Ventricular Hypertrophy in Hypertension	Cardiology	2002	4
41	N-Terminal ProBNP: Marker of Systolic Dysfunction or Nonspecific Indicator of Cardiac Disease?	Cardiology	2003	4
42	Variable Interindividual Responses to Antiplatelet Therapies – Do They Exist, Can We Measure Them, and Are They Clinically Relevant?	Cardiology	2001	3
43	EARTH: Endothelin_A Receptor Antagonist Trial in Heart Failure	Cardiology	2001	3
44	Microalbuminuria Is Associated with Increased Risk of Death in Patients with Myocardial Infarction	Cardiology	2001	3
45	The Impact of Biomarkers and Surrogate End Points on Regulatory Approval of New Drugs	Cardiology	2002	3
46	Aggrenox^® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events	Cardiology	2002	3
47	Statins: Monotherapy or Combination Strategy for the Treatment of Dyslipidemia	Cardiology	2002	3
48	Use of Intravascular Ultrasound in Clinical Trials	Cardiology	2002	3
49	Assessment of Quality of Life in Pharmacological Treatment of Atrial Fibrillation	Cardiology	2003	3
50	Nuclear Cardiology Core Laboratory: State of the Art	Cardiology	2003	3

Scientometrics

Overviews

Citing Bodies

Cardiology

Top Articles